Keyword: Ocular Therapeutix

Valeant, Ocular Therapeutix get CRLs tied to manufacturing

Just days after Valeant Pharmaceuticals' plans for a new eye drug were upended by a complete response letter (CRL) tied to its manufacturing operations, Ocular Therapeutix got one as well. It's the fourth time this year that a drug approval has been sidelined because the FDA was not satisfied with the manufacturing facility in which the drug was to be produced.